<?xml version="1.0" encoding="UTF-8"?>
<p>This article reviews the history of Ebola virus outbreaks in DRC with particular attention to its effect on pregnant women and their infants, and examines the development, accessibility and distribution of the rVSV-ZEBOV vaccine to pregnant and lactating women during the ongoing outbreak that began in Kivu province in 2018. Also examined is the policy of exclusion of pregnant and lactating women and their infants from the clinical trials, and subsequently the distribution, of this vaccine through the most recent three Ebola epidemics [
 <xref rid="B6-vaccines-08-00038" ref-type="bibr">6</xref>,
 <xref rid="B10-vaccines-08-00038" ref-type="bibr">10</xref>,
 <xref rid="B11-vaccines-08-00038" ref-type="bibr">11</xref>,
 <xref rid="B12-vaccines-08-00038" ref-type="bibr">12</xref>,
 <xref rid="B13-vaccines-08-00038" ref-type="bibr">13</xref>,
 <xref rid="B14-vaccines-08-00038" ref-type="bibr">14</xref>,
 <xref rid="B15-vaccines-08-00038" ref-type="bibr">15</xref>,
 <xref rid="B16-vaccines-08-00038" ref-type="bibr">16</xref>,
 <xref rid="B17-vaccines-08-00038" ref-type="bibr">17</xref>,
 <xref rid="B18-vaccines-08-00038" ref-type="bibr">18</xref>,
 <xref rid="B19-vaccines-08-00038" ref-type="bibr">19</xref>,
 <xref rid="B20-vaccines-08-00038" ref-type="bibr">20</xref>,
 <xref rid="B21-vaccines-08-00038" ref-type="bibr">21</xref>,
 <xref rid="B22-vaccines-08-00038" ref-type="bibr">22</xref>].
</p>
